HomeANTX • NASDAQ
add
AN2 Therapeutics Inc
Previous close
$3.77
Day range
$3.47 - $4.01
Year range
$1.00 - $6.91
Market cap
131.54M USD
Avg Volume
2.64M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.32M | 8.24% |
Net income | -8.71M | -15.79% |
Net profit margin | — | — |
Earnings per share | -0.29 | -15.08% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 58.00M | -30.64% |
Total assets | 61.95M | -32.73% |
Total liabilities | 8.89M | -13.17% |
Total equity | 53.06M | — |
Shares outstanding | 35.94M | — |
Price to book | 1.94 | — |
Return on assets | -36.06% | — |
Return on capital | -41.06% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.71M | -15.79% |
Cash from operations | -5.24M | 0.70% |
Cash from investing | 7.17M | 204.27% |
Cash from financing | 0.00 | — |
Net change in cash | 1.94M | 115.95% |
Free cash flow | -2.40M | -36.50% |
About
Founded
2017
Headquarters
Website
Employees
21
